Stock DNA
Pharmaceuticals & Biotechnology
EUR 66 Million ()
NA (Loss Making)
NA
0.00%
3.05
-227.51%
11.01
Revenue and Profits:
Net Sales:
6 Million
(Quarterly Results - Sep 2017)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.74%
0%
31.74%
6 Months
-24.44%
0%
-24.44%
1 Year
8.99%
0%
8.99%
2 Years
-35.26%
0%
-35.26%
3 Years
-63.14%
0%
-63.14%
4 Years
-70.0%
0%
-70.0%
5 Years
-64.1%
0%
-64.1%
BRAIN Biotech AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.67%
EBIT Growth (5y)
-8.26%
EBIT to Interest (avg)
-6.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.05
Sales to Capital Employed (avg)
1.06
Tax Ratio
1.77%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
7.85
EV to EBIT
-5.70
EV to EBITDA
-9.99
EV to Capital Employed
2.69
EV to Sales
1.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-47.20%
ROE (Latest)
-227.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Sep'24
Sep'24
Sep'23
Change(%)
Net Sales
54.60
55.30
-1.27%
Operating Profit (PBDIT) excl Other Income
-5.20
-2.10
-147.62%
Interest
2.00
0.90
122.22%
Exceptional Items
0.30
0.40
-25.00%
Consolidate Net Profit
-11.10
-8.10
-37.04%
Operating Profit Margin (Excl OI)
-182.60%
-121.40%
-6.12%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2024 is -1.27% vs 11.72% in Sep 2023
Consolidated Net Profit
YoY Growth in year ended Sep 2024 is -37.04% vs -28.57% in Sep 2023
About BRAIN Biotech AG 
BRAIN Biotech AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






